| Financial Year |
March 31 2023 |
| Monetary Funds |
4,136,657,701.60 |
| Held-for-trading Financial Assets |
432,882,915.48 |
| Notes Receivable |
29,321,776.37 |
| Accounts Receivable |
1,778,302,632.62 |
| Advances to Suppliers |
202,710,484.42 |
| Other Receivables |
16,293,705.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,098,934,909.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
204,486,274.01 |
| Other Current Assets |
463,806,980.92 |
| Total Current Assets |
9,950,936,601.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,601,319.96 |
| Investment Properties |
-- |
| Fixed Assetes |
1,277,106,013.62 |
| Under-construction Projects |
13,534,473.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
434,059,170.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
388,594,454.72 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,279,513,169.48 |
| Total Assets |
13,230,449,770.86 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,131,662,500.00 |
| Accounts Payable |
2,680,304,415.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
216,984,686.06 |
| Taxes Payable |
176,108,717.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
140,905,501.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
47,417,734.27 |
| Other Current Liabilities |
175,303,289.40 |
| Sub-Total of Current Liabilities |
5,628,885,498.43 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,462,165.30 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
161,523,275.35 |
| Total Liabilities |
5,790,408,773.78 |
| Paid-In Capital(Or Share Stock) |
808,654,476.00 |
| Capital Surplus |
138,457,638.44 |
| Surplus Reserve |
356,924,811.32 |
| LESS:Treasury Stock |
175,940,916.05 |
| Undistributed Profits |
6,299,491,656.27 |
| Minority Stockholder's Interest |
36,502,620.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,403,538,376.61 |
| Owner's Equity（Stockholder's Equity） |
7,440,040,997.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,230,449,770.86 |
